Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis

NCT01081782 is registered in ClinicalTrials.gov with Ono Pharma USA Inc as lead sponsor.

NCT NCT01081782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01081782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
Lead sponsor
Ono Pharma USA Inc
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2010
Completion date
December 31, 2011
Enrollment
407 (actual)
Sites
86

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis